6 completed, 3 recruiting, 3 unknown, 2 active not recruiting. 10 Phase 4, 4 Phase 3, 2 Not applicable, 2 Phase 2.
Follow Sodium Chloride 0.9% Inj: new trials by email Literature Review of Sodium Chloride 0.9% Inj trials Research Report on Sodium Chloride 0.9% Inj
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tranexamic Acid in Pediatric Idiopathic Scoliosis Surgery Tranexamic Acid Bolus Plus Infusion, Sodium Chloride 0.9% Inj, Tranexamic Acid Bolus Only - Scoliosis Idiopathic, Scoliosis; Adolescence | Not applicable | Recruiting | Poznan University of Medical Sciences | 90 | 2026-06-01 | 2026-07-01 |
| Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain Preemptive Dexmedetomidine injection, Sodium Chloride 0.9% Inj - Pain Management, Noncardiac Surgery | Phase 4 | Not yet recruiting | China International Neuroscience Institution | 208 | 2025-04-03 | 2025-04-09 |
| Tailoring Obesity Treatment Trial Pramlintide Acetate 1 MG/ML, Semaglutide Pen Injector, Sodium Chloride 0.9% Inj - Obesity, Appetite Regulation | Phase 2 / Phase 3 | Withdrawn | Esbjerg Hospital - University Hospital of Southern Denmark | 2025-04-01 | 2026-04-17 | |
| Botulinum Toxin Injection in the UES for R-CPD botulinum toxin type A, Sodium Chloride 0.9% Inj - Retrograde Cricopharyngeus Dysfunction | Phase 4 | Active not recruiting | AZ Delta | 50 | 2024-09-02 | 2025-12-08 |
| Oxytocin Effectiveness in First Trimester Dilatation and Curettage Oxytocin, Sodium Chloride 0.9% Inj - Missed Abortion | Not applicable | Unknown | Assuta Ashdod Hospital | 160 | 2024-09-01 | 2024-08-13 |
| Tocilizumab for Painful Chronic Pancreatitis Tocilizumab 20 MG/ML [Actemra], Sodium Chloride 0.9% Inj - Pancreatitis, Chronic | Phase 2 | Active not recruiting | Soren Schou Olesen | 32 | 2024-05-21 | 2026-08-14 |
| Anti-viral Action Against Type 1 Diabetes Autoimmunity Comirnaty Injectable Product, Sodium Chloride 0.9% Inj - Diabetes Mellitus, Type 1 | Phase 4 | Recruiting | Technical University of Munich | 2252 | 2024-05-08 | 2025-09-23 |
| Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG Calcium Chloride, Sodium Chloride 0.9% Inj - Atrial Fibrillation | Phase 3 | Unknown | Helwan University | 100 | 2024-03-14 | 2024-04-22 |
| The Role of Peripheral Afferents in Modulating Post-stroke Central Pain Lidocaine 20mg/ml, Levobupivacaine Hydrochloride 1.25 MG/ML, Sodium Chloride 0.9% Inj - Stroke | Phase 3 | Completed | Institut National de la Santé Et de la Recherche Médicale, France | 33 | 2024-02-09 | 2026-10-19 |
| Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia Dexmedetomidine Injectable Solution, Sodium Chloride 0.9% Inj - Epilepsy, Radiofrequency Ablation | Phase 4 | Completed | China International Neuroscience Institution | 28 | 2024-01-15 | 2026-09-10 |
| Effect of Systematic Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery Sodium Chloride 0.9% Inj, 0,1mg/kg Dexamethasone, 0,2mg/kg Dexamethasone - Ankle Disease, Foot Deformities | Phase 4 | Completed | Poznan University of Medical Sciences | 90 | 2023-10-17 | 2025-09-18 |
| Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery Sodium Chloride 0.9% Inj, 0,1mg/kg Dexamethasone, 0,2mg/kg Dexamethasone - Wrist Disease, Hand Injuries and Disorders | Phase 4 | Completed | Poznan University of Medical Sciences | 90 | 2023-09-18 | 2026-05-11 |
| Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Ferinject, Sodium Chloride 0.9% Inj - Myocardial Infarction, Acute | Phase 4 | Recruiting | Wroclaw Medical University | 1000 | 2022-09-22 | 2025-07-30 |
| Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline Sodium Chloride 0.9% Inj, Bacteriostatic Sodium Chloride 0.9 % INJECTION VIAL (ML) - Injection Site Irritation, Injection Site Bruising | Phase 4 | Unknown | Jeffrey Alan Klein, MD | 32 | 2021-11-01 | 2021-11-05 |
| Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery Sodium Chloride 0.9% Inj, Tranexamic Acid - Spinal Fusion | Phase 3 | Terminated | Exela Pharma Sciences, LLC. | 5 | 2018-10-17 | 2021-06-21 |
| A Study Investigating the Efficacy of GON Blocks. Combined Depo-Medrone and Lidocaine, Sodium Chloride 0.9% Inj - Migraine, Chronic Migraine, Headache | Phase 4 | Completed | Barts & The London NHS Trust | 8 | 2018-02-14 | 2020-03-27 |
| Ketamine Analgesia in Third Molar Surgery S-Ketamine, Sodium Chloride 0.9% Inj - Pain, Postoperative | Phase 4 | Completed | Dalarna County Council, Sweden | 168 | 2017-02-14 | 2022-10-12 |
Agnosia (2) · Abortion, Missed (1) · Atrial Fibrillation (1) · COVID-19 (1) · Cerebral Palsy (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Digestive System Diseases (1) · Dilatation, Pathologic (1) · Disease (1) · Epilepsy (1) · Foot Deformities (1) · Foot Diseases (1) · Hand Injuries (1) · Headache (1)
Poznan University of Medical Sciences (3) · China International Neuroscience Institution (2) · AZ Delta (1) · Assuta Ashdod Hospital (1) · Barts & The London NHS Trust (1) · Dalarna County Council, Sweden (1) · Esbjerg Hospital - University Hospital of Southern Denmark (1) · Exela Pharma Sciences, LLC. (1) · Helwan University (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Jeffrey Alan Klein, MD (1) · Soren Schou Olesen (1) · Technical University of Munich (1) · Wroclaw Medical University (1)
Poland (4) · Belgium (2) · China (2) · Denmark (2) · Sweden (2) · United Kingdom (2) · United States (2) · Austria (1) · Egypt (1) · France (1) · Germany (1)
Abdelhameed I Ebid (1) · Anette-G. Ziegler (1) · Anish Bahra (1) · Claus Bogh Juhl, MD, phd, professor (1) · Kathelijne G Delsupehe, MD (1) · Lars Sand, Professor, DDS, MD (1) · Leszek Romanowski, Prof.dr hab (1) · Neel Anand, MD (1) · Piotr Ponikowski (1) · Tomasz Kotwicki, Prof.dr hab. (1) · Xinya Wang, Dr (1)
PMID 41272580, PMID 41352236, PMID 42207991
2023 (2), 2014 (1)